Publication | Open Access

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study

Hcv InfectionViral HepatitisHcv-infected DonorsAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyAntiviral DrugHivLiver TransplantationMedicinePhase 3